STERIS logo

STERIS (STE) Q4 2026 Annual Earnings

STE·Reported May 11, 2026·After market close

STERIS reported Q4 2026 revenue of $1.6B (+7.3% YoY), missed analyst consensus of $1.6B by $6.2M. Diluted EPS came in at $2.83 (+3.3% YoY), missed the $2.86 consensus by $0.03. STERIS reports across 3 business segments, led by Healthcare, Applied Sterilization Technologies (AST), and Life Sciences.

Revenue
$1.6Bmissed by $6.2M
Consensus: $1.6B
Diluted EPS
$2.83missed by $0.03
Consensus: $2.86
SEC

SEC Filings

Earnings release8-K · 0001628280-26-033580
Annual report10-K · 0001628280-26-039136

Financial Snapshot

Trailing eight quarters through Q4 2026

View all metrics

Revenue

View metric

Q4 2026 Earnings FAQ

Common questions about STERIS's Q4 2026 earnings report.

STERIS (STE) reported Q4 2026 earnings on May 11, 2026 after market close.

STERIS reported revenue of $1.6B and diluted EPS of $2.83 for Q4 2026.

Revenue missed the consensus estimate of $1.6B by $6.2M. EPS missed the consensus estimate of $2.86 by $0.03.

Compared to the same quarter a year prior, revenue grew 7.3% from $1.5B a year earlier and diluted EPS grew 3.3% from $2.74.

You can read the 8-K earnings release (0001628280-26-033580) and the 10-K periodic report (0001628280-26-039136) directly on SEC EDGAR. The filing index links above go to sec.gov.